Seattle-based Clinical Research Organization is Awarded a National Cancer Institute (NCI) Contract for Oncology Biospecimen Collection
SEATTLE, March 30, 2016
Global BioClinical (GBC), http://www.globalbioclinical.com, is pleased to announce that it has been awarded a contract from the National Institutes of Health (NIH) / National Cancer Institute (NCI) to support the Clinical Proteomics Tumor Analysis Consortium (CPTAC) Project (http://proteomics.cancer.gov ). The primary objective of the CPTAC Project is to improve the ability to diagnose, treat, and prevent cancer. The CPTAC Project identifies protein alterations in cancer and related biological processes and provides this data, along with associated assays and protocols, to the public.
Through its international network of affiliated clinical sites, Global BioClinical (GBC) will facilitate collaboration between regions of the world that have high cancer prevalence, late stage detection, and fewer treatment options and this US government-funded research project. Global BioClinical (GBC) will establish and manage a biospecimen collection network, including oncology treatment centers, that will enroll subjects diagnosed with various types of cancer and who are scheduled to undergo surgical treatment for their disease. Participating subjects will consent to donate a pre-surgical blood sample and resected surplus surgical tissues. Collected biospecimens, and de-identified medical and pathology information, will be delivered to a CPTAC biospecimen testing laboratory where they will undergo proteomic analysis. The collected biospecimens must meet a stringent set of qualification criteria so that extracted DNA and RNA is suitable for advanced genomic and proteomic analysis and sequencing technologies.
In addition to developing and managing a network of biospecimen source sites, Global BioClinical has extended its CPTAC collaboration to include established research biospecimen provider BioReclamation IVT (http://www.bioreclamationivt.com) based inBaltimore, MD and their affiliated biospecimen quality control laboratory in Chestertown, MDformally known as Integrated Laboratory Bioservices (ILS Bioservices).
About Global BioClinical:
Global BioClinical (GBC), http://www.globalbioclinical.com, is a contract consulting and clinical research organization (CRO) with core expertise in organizational and project management, clinical trial planning and execution, and human biospecimens. GBC works with clients in the life sciences and healthcare research sector including early-stage and established medical device and biotechnology companies, pharmaceutical companies, medical centers and health systems, research and academic institutions, government agencies, venture capital groups, and not-for-profit groups. GBC supports predictive, prognostic, personalized, and participatory medicine with the goal of moving healthcare products to the market quickly, with less risk, and with a greater return on investment.
BioreclamationIVT is a worldwide provider of biological and in vitro products to pharmaceutical, biotechnology, diagnostic, academic, contract research organizations (CRO) and government institutions. BioreclamationIVT specializes in providing researchers with normal and disease state matrices produced from human whole blood, plasma, serum, tissues and other fluids which are used in drug discovery, compound development, clinical and research diagnostics. BioreclamationIVT provides support to researchers via a strong network of collection sites and extensive lab work to assure the highest quality of every specimen.
GBC – GLOBAL BIOCLINICAL
Expertise-Based Clinical Research Services
Consulting – Business – Trials – Biospecimens
113 Cherry St., Suite 80042
Seattle, WA 98104-2205U.S.A.
Linked In: www.linkedin.com/company/global-bioclinical
Biospecimens For Your Research
99 Talbot Blvd
Chestertown, MD 21620
Main +1 410-810-7506
Fax +1 410-810-7508
Please click here to view the press release online.